Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InfuSystem Holdings (INFU) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $955000.0.

  • InfuSystem Holdings' Cash & Equivalents rose 15131.58% to $955000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $955000.0, marking a year-over-year increase of 15131.58%. This contributed to the annual value of $527000.0 for FY2024, which is 12813.85% up from last year.
  • InfuSystem Holdings' Cash & Equivalents amounted to $955000.0 in Q3 2025, which was up 15131.58% from $720000.0 recorded in Q2 2025.
  • In the past 5 years, InfuSystem Holdings' Cash & Equivalents ranged from a high of $2.8 million in Q1 2021 and a low of $134000.0 during Q2 2023
  • Over the past 5 years, InfuSystem Holdings' median Cash & Equivalents value was $311000.0 (recorded in 2022), while the average stood at $545157.9.
  • Within the past 5 years, the most significant YoY rise in InfuSystem Holdings' Cash & Equivalents was 80524.59% (2021), while the steepest drop was 9807.21% (2021).
  • Quarter analysis of 5 years shows InfuSystem Holdings' Cash & Equivalents stood at $186000.0 in 2021, then decreased by 11.29% to $165000.0 in 2022, then surged by 40.0% to $231000.0 in 2023, then soared by 128.14% to $527000.0 in 2024, then surged by 81.21% to $955000.0 in 2025.
  • Its last three reported values are $955000.0 in Q3 2025, $720000.0 for Q2 2025, and $1.5 million during Q1 2025.